Kalaris Therapeutics Inc. (KLRS)

Last Closing Price: 4.08 (2025-08-29)

Gross Margin (Quarterly)

Gross Margin: A company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage. Calculated as: Gross Income / Total Revenues

Kalaris Therapeutics Inc. (KLRS) Gross Margin data is not available.

Figures for fiscal quarter ending 2025-06-30
Income Statement Financials
--
$-11.35M
--
--
$12.26M
$-12.26M
$0.91M
$-11.35M
$-11.35M
$-11.35M
$-11.35M
$-11.35M
$-11.35M
$-12.26M
$-12.26M
18.70M
18.70M
$-0.61
$-0.61
Balance Sheet Financials
$91.65M
--
$1.19M
$92.84M
$7.65M
--
$32.08M
$39.73M
$53.12M
$53.12M
$53.12M
18.70M
Cash Flow Statement Financials
$-19.98M
--
$107.27M
$1.64M
$88.93M
$87.29M
$0.96M
--
--
Fundamental Metrics & Ratios
11.98
--
--
--
--
Gross Margin
--
--
--
--
--
--
$-19.98M
--
--
--
--
--
--
--
-21.37%
-21.37%
-12.23%
-21.37%
$2.84
$-1.07
$-1.07